EUVIMEDEUVIMED entdecken
LeserbriefKommentarOpen Access · CC BY-NC-SA 4.0

Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial

Krishnagopal Srikanth, Dhruval A Khurana

Indian Journal of Ophthalmology · 2023

DOI: 10.4103/ijo.ijo_3282_22 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Indian Journal of Ophthalmology, 2023. Verfasst von Krishnagopal Srikanth und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth, Pondicherry, India. Hauptthemen laut MEDLINE: Glaucoma, Open-Angle, Glaucoma, Ocular Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dear Editor, We read with interest the article titled “Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial” by Nivean et al.[1] published in Indian Journal of Ophthalmology. This is a novel study, enlightening the effect of 2% dorzolamide in glaucoma patients (open-angle glaucoma, normal tension glaucoma). However, we would like to point out certain lacunae in this study, apart from those mentioned by the investigators. The research team was not blinded during the study; their blinding could have avoided the bias. Even though the study group was very small, it should have been divided into two groups and the second group should have received a different drug other than the trial drug (2% dorzolamide), which would have made the study more robust. Details (name and make) of the instrument used to analyze ocular blood flow could have been mentioned. Despite the short duration of the study, parameters other than intraocular pressure (IOP), like serial monitoring of retinal nerve fiber layer (RNFL) thickness, could have made the study more valuable. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glaucoma, Open-AngleGlaucomaOcular HypertensionHumansCarbonic Anhydrase InhibitorsEyeIntraocular PressureOphthalmic SolutionsSulfonamidesThiophenes

Substanzen

Carbonic Anhydrase InhibitorsOphthalmic SolutionsdorzolamideSulfonamidesThiophenes

Autor:innen und Institutionen

  • Department of Ophthalmology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth, Pondicherry, India.

Zitieren

APA

Srikanth, K., & Khurana, D. A. (2023). Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_3282_22

Vancouver

Srikanth K, Khurana DA. Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial. Indian Journal of Ophthalmology. 2023. doi:10.4103/ijo.ijo_3282_22

BibTeX
@article{Srikanth2023,
  author = {Srikanth, Krishnagopal and Khurana, Dhruval A},
  title = {Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial},
  journal = {Indian Journal of Ophthalmology},
  year = {2023},
  doi = {10.4103/ijo.ijo_3282_22}
}
Kostenlos starten →